General Information of Drug (ID: DMEL28G)

Drug Name
BDBM50177019 Drug Info
Synonyms CHEMBL3813863; SCHEMBL17519302; BDBM50177019
Cross-matching ID
PubChem CID
118883505
TTD Drug ID
DMEL28G

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9073931, E2 DMK9FJG N. A. N. A. Patented [2]
US9006244, E2b DMP0TBO N. A. N. A. Patented [3]
US9073931, E1 DM2Z43I N. A. N. A. Patented [2]
US9006244, E1 DMBF1C0 N. A. N. A. Patented [3]
BDBM50177012 DM52IQF N. A. N. A. Patented [1]
US9006244, E2a DMPDF9B N. A. N. A. Patented [3]
67S DMJL1MB N. A. N. A. Patented [1]
US9073931, E3 DMCYM8P N. A. N. A. Patented [2]
desmosterol DMV8SUM Discovery agent N.A. Investigative [4]
L-783483 DM6OTGE Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oxysterols receptor LXR-alpha (NR1H3) TTECBXN NR1H3_HUMAN Inhibitor [1]

References

1 Piperazine derivatives as liver X receptor modulators. US10144715.
2 Liver X receptor modulators. US9073931.
3 Liver X receptor modulators. US9006244.
4 Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem. 2006 Sep 22;281(38):27816-26.
5 A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a). Endocrinology. 2002 Jul;143(7):2548-58.